News & Updates

Memories of childhood maltreatment affect mental health more than the abuse itself
Memories of childhood maltreatment affect mental health more than the abuse itself
04 Aug 2023
HDP exposure in gestation, maternal hypertension spell increased hypertension risk in offspring
HDP exposure in gestation, maternal hypertension spell increased hypertension risk in offspring
03 Aug 2023

Exposure to hypertensive disorders of pregnancy (HDP) in gestation and maternal hypertension both contribute to an elevated risk of chronic hypertension in offspring, as reported in a study.

HDP exposure in gestation, maternal hypertension spell increased hypertension risk in offspring
03 Aug 2023
Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication
Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication
03 Aug 2023

In the first-line treatment of Helicobacter pylori (H pylori) infection, 14-day hybrid therapy and 10-day bismuth quadruple therapy demonstrate superiority over 14-day high-dose dual therapy, reports a Taiwan study. However, high-dose therapy results in fewer adverse events than hybrid bismuth quadruple therapies.

Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication
03 Aug 2023
Synbiotics help reduce weight in adults with overweight, obesity
Synbiotics help reduce weight in adults with overweight, obesity
03 Aug 2023
Abrocitinib effectively controls AD regardless of dosing regimen
Abrocitinib effectively controls AD regardless of dosing regimen
03 Aug 2023 byAudrey Abella

In patients with moderate-to-severe atopic dermatitis (AD), flexible dosing of abrocitinib, an oral, once-daily Janus kinase 1-selective inhibitor, appeared as beneficial as the continuous high-dose regimen. This was demonstrated in a post hoc analysis of two studies from the JADE* clinical development programme.

Abrocitinib effectively controls AD regardless of dosing regimen
03 Aug 2023